TC BioPharm Work with University College London on Cancer Project

TC BioPharm have joined forces with University College London to develop treatment for Leukaemia.

The agreement aims to progress UCL’s gene-modified T cell therapies that are capable of treating cancers of the blood.

To read the full article, click here.